TD Cowen Maintains Outperform on Profound Medical, Raises Price Target to $18

Benzinga · 05/11/2023 11:17
TD Cowen analyst Joshua Jennings maintains Profound Medical (NASDAQ:PROF) with a Outperform and raises the price target from $14 to $18.